The Latin America, Middle East and Africa Intragastric Balloon Market would witness market growth of 13.4% CAGR during the forecast period (2020-2026).
Increased use of minimally invasive techniques over the forecast period would boost market growth. Intragastric balloons are orally introduced and do not require any incision accompanied by balloon inflation with a saline solution or gas. Growing approval of the intragastric balloon system will serve as useful non-surgical treatment options for the treatment of diseases linked to obesity and weight.
Saline-filled intragastric balloon business accounted for a substantial market share. Ability to reduce weight more efficiently and rapidly by methylene blue dye to detect silicone balloon deflation and will benefit the adoption rate. The American Society of Gastrointestinal Endoscopy indicates that most patients undergoing saline-filled intragastric balloon treatment tend to lose around a quarter of their body mass. As a result, the above-mentioned factors will foster future segmental growth.
The gas-filled balloon market is anticipated to rise at an exponential growth rate over the forecast period. The segmental growth is attributed to three layers of bacteria-resistant material, which reduces the chances of undesirable effects and improves the comfort of patients in the event of deflation. In addition, the balloon’s quality to improve patient compliance in spontaneous deflation removal and avoidance will stimulate market growth rate.
Based on Administration, the market is segmented into Endoscopy and Pill Form. Based on Type, the market is segmented into Single, Dual and Triple. Based on Filling Material, the market is segmented into Gas Filled and saline Filled. Based on End Use, the market is segmented into Clinics, Hospitals and Ambulatory Surgical Centers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil
Scope of the Study
Market Segmentation:
By Administration

  • Endoscopy and
  • Pill Form


By Type

  • Single
  • Dual and
  • Triple


By Filling Material

  • Gas Filled and
  • Saline Filled


By End Use

  • Clinics
  • Hospitals and
  • Ambulatory Surgical Centers


By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA


Companies Profiled

  • Sientra, Inc. (Silimed, Inc.)
  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Allurion Technologies, Inc.
  • Helioscopie SA (Sante Actions Group)
  • Districlass Medical SA
  • Spatz FGIA, Inc.
  • Duomed Group (Life Partners Europe)
  • Medsil


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free